NPI: 1487607784 · TUCSON, AZ 85741 · Radiology Clinic/Center · NPI assigned 05/18/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 221,842 | $7.97M |
| 2019 | 232,942 | $8.94M |
| 2020 | 181,919 | $6.99M |
| 2021 | 188,612 | $6.71M |
| 2022 | 184,560 | $6.66M |
| 2023 | 178,271 | $6.09M |
| 2024 | 116,864 | $4.45M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 43,068 | 38,882 | $6.19M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 41,022 | 38,020 | $6.15M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11,104 | 10,319 | $5.46M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 20,816 | 18,730 | $4.39M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 6,866 | 6,572 | $2.91M |
| 70450 | Computed tomography, head or brain; without contrast material | 10,350 | 9,530 | $2.68M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5,451 | 5,083 | $2.21M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,741 | 3,535 | $1.55M |
| G0378 | Hospital observation service, per hour | 12,052 | 7,177 | $1.44M |
| 59025 | Fetal non-stress test | 8,637 | 5,422 | $1.22M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9,516 | 8,403 | $1.03M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15,020 | 14,037 | $845K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 18,631 | 17,424 | $836K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 2,226 | 2,139 | $715K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2,045 | 1,928 | $687K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3,357 | 3,155 | $669K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 13,080 | 11,203 | $658K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,624 | 7,232 | $632K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1,687 | 1,587 | $536K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 20,734 | 19,801 | $433K |
| 71046 | Radiologic examination, chest; 2 views | 12,465 | 11,720 | $377K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,193 | 1,080 | $350K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,907 | 2,864 | $341K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5,902 | 5,745 | $268K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5,332 | 2,012 | $263K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3,630 | 3,518 | $246K |
| 93971 | 1,915 | 1,794 | $222K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 462 | 432 | $209K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,094 | 5,320 | $202K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,985 | 1,875 | $201K |
| 70498 | 636 | 599 | $180K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 173 | 156 | $149K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,467 | 2,358 | $134K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,429 | 1,359 | $123K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,431 | 846 | $122K |
| 88342 | 7,946 | 7,093 | $117K | |
| 10060 | 635 | 599 | $115K | |
| 99215 | Prolong outpt/office vis | 1,423 | 1,329 | $106K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,312 | 2,221 | $102K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5,570 | 1,997 | $101K |
| 96361 | Intravenous infusion, hydration; each additional hour | 23,230 | 20,259 | $95K |
| 43249 | 248 | 227 | $88K | |
| 73610 | 2,500 | 2,319 | $88K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 31,808 | 26,399 | $86K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 158 | 152 | $86K |
| 73564 | 2,689 | 2,400 | $85K | |
| 73130 | 2,295 | 2,119 | $78K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,208 | 2,078 | $78K |
| 12001 | 783 | 754 | $71K | |
| 43235 | 233 | 220 | $68K | |
| 72100 | 2,332 | 2,203 | $67K | |
| 73630 | 2,997 | 2,766 | $65K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,661 | 2,545 | $63K |
| 93458 | 52 | 47 | $60K | |
| 97161 | 2,154 | 2,009 | $60K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 326 | 241 | $59K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 814 | 798 | $54K |
| 73110 | 1,623 | 1,508 | $52K | |
| 47563 | 12 | 12 | $52K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 198 | 117 | $50K |
| 29125 | 400 | 379 | $49K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 505 | 477 | $47K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,143 | 3,587 | $43K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,825 | 2,364 | $43K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,954 | 2,804 | $41K |
| 93970 | 462 | 430 | $40K | |
| 71250 | 446 | 432 | $37K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 8,199 | 7,422 | $36K |
| 80053 | Comprehensive metabolic panel | 51,419 | 43,799 | $34K |
| 73030 | 2,484 | 2,189 | $34K | |
| C1776 | Joint device (implantable) | 30 | 26 | $33K |
| 58571 | 14 | 14 | $33K | |
| 86920 | 511 | 359 | $30K | |
| 36430 | 191 | 150 | $29K | |
| 71101 | 668 | 632 | $27K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 30,977 | 27,099 | $26K |
| 77066 | Tomosynthesis, mammo | 151 | 147 | $26K |
| 77080 | 236 | 230 | $24K | |
| 76642 | 999 | 830 | $23K | |
| 74018 | 1,809 | 1,649 | $22K | |
| 84484 | 22,491 | 16,121 | $21K | |
| 78451 | 75 | 67 | $20K | |
| 87507 | 180 | 169 | $19K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 786 | 667 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,922 | 10,013 | $17K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 123 | 116 | $17K |
| 12011 | 289 | 280 | $17K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5,487 | 3,699 | $17K |
| 70496 | 696 | 657 | $16K | |
| 73080 | 768 | 719 | $16K | |
| 72040 | 931 | 891 | $16K | |
| 70491 | 42 | 40 | $16K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 21,290 | 17,194 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 343 | 330 | $14K |
| 97535 | Self-care/home management training, each 15 minutes | 246 | 137 | $13K |
| 87070 | 1,087 | 983 | $13K | |
| 73502 | 1,069 | 992 | $12K | |
| 72131 | 178 | 171 | $12K | |
| 93976 | 3,481 | 3,307 | $12K | |
| 99205 | Prolong outpt/office vis | 146 | 136 | $12K |
| 62323 | 44 | 40 | $12K | |
| 82805 | 529 | 461 | $11K | |
| 70486 | 276 | 261 | $11K | |
| 86850 | 3,076 | 2,755 | $11K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,311 | 1,209 | $11K |
| 12002 | 123 | 119 | $10K | |
| 71045 | Radiologic examination, chest; single view | 19,310 | 17,535 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 68,158 | 56,394 | $9K |
| C1726 | Catheter, balloon dilatation, non-vascular | 126 | 122 | $9K |
| 97597 | 640 | 344 | $9K | |
| 77065 | Tomosynthesis, mammo | 110 | 100 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 10,957 | 9,238 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | 19,169 | 16,662 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 16,288 | 14,971 | $7K |
| 73590 | 589 | 531 | $7K | |
| 76830 | Ultrasound, transvaginal | 1,891 | 1,812 | $7K |
| C1889 | Implantable/insertable device, not otherwise classified | 257 | 247 | $6K |
| 93351 | 30 | 26 | $6K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,474 | 1,388 | $6K |
| 93798 | 144 | 27 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 122 | 114 | $6K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 28 | 25 | $5K |
| 97162 | 134 | 124 | $5K | |
| 93017 | 599 | 541 | $5K | |
| 93975 | 314 | 297 | $5K | |
| 36415 | Collection of venous blood by venipuncture | 80,685 | 61,578 | $5K |
| 74240 | 38 | 38 | $5K | |
| 87186 | 5,224 | 4,831 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 21,348 | 20,044 | $3K |
| 73090 | 323 | 298 | $3K | |
| 74220 | 18 | 18 | $3K | |
| 83690 | 22,813 | 20,320 | $2K | |
| 84703 | 17,349 | 16,016 | $2K | |
| 76801 | 1,533 | 1,416 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 11,594 | 11,117 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,788 | 2,658 | $2K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 12 | 12 | $2K |
| 84702 | 3,186 | 2,852 | $2K | |
| 76536 | 24 | 24 | $1K | |
| 81001 | 27,444 | 24,952 | $1K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 160 | 133 | $1K |
| 96376 | 4,610 | 3,977 | $1K | |
| 72072 | 25 | 24 | $1K | |
| 73562 | 132 | 121 | $961.70 | |
| 82962 | 17,298 | 9,830 | $959.20 | |
| 97165 | 86 | 80 | $953.46 | |
| 84443 | Thyroid stimulating hormone (TSH) | 4,324 | 3,977 | $929.78 |
| 80061 | Lipid panel | 1,909 | 1,762 | $858.55 |
| 81025 | 12,133 | 11,594 | $782.65 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,305 | 1,222 | $770.68 |
| 72128 | 12 | 12 | $770.22 | |
| 72070 | 77 | 75 | $765.90 | |
| 85379 | 4,983 | 4,690 | $761.30 | |
| 76775 | 70 | 66 | $743.41 | |
| C1781 | Mesh (implantable) | 46 | 42 | $735.21 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,786 | 2,653 | $653.98 |
| 83735 | 7,503 | 6,370 | $641.38 | |
| 83880 | 3,423 | 3,092 | $567.33 | |
| 81003 | 15,865 | 14,756 | $559.19 | |
| 87040 | 4,541 | 2,502 | $554.48 | |
| 82248 | 2,824 | 2,597 | $545.86 | |
| 97116 | 274 | 158 | $405.44 | |
| 87081 | 2,117 | 2,010 | $360.61 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 12,735 | 9,889 | $358.01 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,805 | 2,606 | $345.75 |
| 87077 | 5,302 | 4,898 | $340.06 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 26,854 | 22,976 | $333.37 |
| 90715 | 2,437 | 2,335 | $321.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 10,713 | 9,551 | $300.65 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 19,523 | 17,472 | $258.93 |
| 85610 | 11,171 | 9,948 | $256.33 | |
| 73140 | 867 | 808 | $251.51 | |
| 83605 | 3,980 | 3,310 | $246.01 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 18,796 | 17,238 | $244.82 |
| 85027 | 6,034 | 4,703 | $243.84 | |
| 80143 | 2,641 | 2,379 | $208.37 | |
| 69209 | 18 | 13 | $205.52 | |
| 80179 | 2,629 | 2,329 | $202.96 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,243 | 1,976 | $198.39 |
| 82077 | 3,733 | 3,335 | $184.85 | |
| 88307 | 440 | 403 | $166.49 | |
| 73660 | 43 | 41 | $154.62 | |
| J2060 | Injection, lorazepam, 2 mg | 4,349 | 3,461 | $142.91 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,122 | 5,056 | $135.91 |
| 84512 | 2,118 | 1,729 | $134.54 | |
| 84100 | 1,500 | 1,201 | $129.59 | |
| 97750 | 13 | 13 | $129.13 | |
| 86901 | 4,255 | 3,858 | $128.36 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 7,195 | 5,829 | $127.26 |
| J0690 | Injection, cefazolin sodium, 500 mg | 7,073 | 6,136 | $119.12 |
| 86900 | 4,257 | 3,858 | $114.88 | |
| 84132 | 1,243 | 1,092 | $112.42 | |
| 92610 | 20 | 15 | $110.57 | |
| 85730 | 3,603 | 3,236 | $81.45 | |
| 82150 | 2,606 | 2,474 | $62.53 | |
| 82550 | 1,625 | 1,437 | $59.12 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,552 | 4,062 | $46.75 |
| 82565 | 694 | 636 | $43.82 | |
| 87210 | 1,536 | 1,462 | $39.23 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 270 | 251 | $34.33 |
| J2704 | Injection, propofol, 10 mg | 21,815 | 20,354 | $34.12 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,627 | 3,318 | $33.81 |
| 94760 | 5,071 | 3,106 | $32.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,120 | 990 | $31.76 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 13,410 | 11,987 | $30.94 |
| 80076 | 108 | 104 | $26.26 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 406 | 310 | $25.98 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,065 | 957 | $21.04 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,702 | 2,527 | $18.20 |
| 84439 | 139 | 131 | $16.97 | |
| J1630 | Injection, haloperidol, up to 5 mg | 926 | 864 | $14.15 |
| 86140 | 680 | 648 | $11.20 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 406 | 311 | $9.81 |
| J1956 | Injection, levofloxacin, 250 mg | 529 | 379 | $8.55 |
| 87046 | 201 | 188 | $8.22 | |
| 87205 | 1,146 | 1,026 | $7.56 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 304 | 276 | $7.15 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 11,208 | 10,275 | $6.49 |
| 85651 | 390 | 374 | $5.77 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 1,787 | 1,676 | $5.34 |
| 81002 | 2,343 | 2,191 | $3.80 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,035 | 1,252 | $3.10 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,849 | 1,548 | $1.38 |
| J8540 | Dexamethasone, oral, 0.25 mg | 773 | 492 | $0.04 |
| 76820 | 118 | 94 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,194 | 1,106 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 599 | 539 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,416 | 740 | $0.00 |
| C1769 | Guide wire | 2,128 | 1,940 | $0.00 |
| 74420 | 161 | 148 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 234 | 175 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 534 | 440 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 53 | 52 | $0.00 |
| 87147 | 1,278 | 1,214 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 287 | 234 | $0.00 |
| 87088 | 611 | 581 | $0.00 | |
| 88304 | 1,221 | 1,168 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 308 | 199 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 57 | 54 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 697 | 475 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 375 | 317 | $0.00 |
| 82607 | 95 | 84 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 643 | 583 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,895 | 2,852 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 30 | 28 | $0.00 |
| 86403 | 172 | 166 | $0.00 | |
| 88309 | 69 | 67 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 60 | 57 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 117 | 113 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 89 | 82 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 12 | 12 | $0.00 |
| 86308 | 25 | 24 | $0.00 | |
| 82270 | 287 | 262 | $0.00 | |
| 86592 | 13 | 12 | $0.00 | |
| 82330 | 17 | 12 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 94 | 84 | $0.00 |
| L0625 | Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf | 41 | 41 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 121 | 111 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 147 | 142 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 58 | 52 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 26 | 25 | $0.00 |
| 82746 | 74 | 64 | $0.00 | |
| 83550 | 13 | 13 | $0.00 | |
| 85652 | 53 | 51 | $0.00 | |
| 76870 | 45 | 43 | $0.00 | |
| J3360 | Injection, diazepam, up to 5 mg | 28 | 26 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 40 | 30 | $0.00 |
| 82435 | 17 | 12 | $0.00 | |
| 88108 | 20 | 14 | $0.00 | |
| 85018 | 15 | 12 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 12 | 12 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 15 | 13 | $0.00 |
| 99152 | 1,141 | 999 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,465 | 1,359 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 108 | 100 | $0.00 |
| C1758 | Catheter, ureteral | 69 | 66 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 989 | 928 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,728 | 1,122 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 1,875 | 1,220 | $0.00 |
| 88360 | 21 | 13 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 581 | 519 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,241 | 1,120 | $0.00 |
| 84550 | 138 | 120 | $0.00 | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 127 | 101 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 891 | 743 | $0.00 |
| 82947 | 135 | 112 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 162 | 133 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 78 | 71 | $0.00 |
| 88313 | 1,757 | 1,663 | $0.00 | |
| 87102 | 18 | 13 | $0.00 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 546 | 514 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 460 | 401 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 59 | 41 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 98 | 87 | $0.00 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 14 | 13 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 155 | 138 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 133 | 130 | $0.00 |
| 77062 | 82 | 77 | $0.00 | |
| 82140 | 50 | 40 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 438 | 383 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 232 | 230 | $0.00 |
| J1245 | Injection, dipyridamole, per 10 mg | 48 | 42 | $0.00 |
| 87075 | 14 | 13 | $0.00 | |
| 90687 | 22 | 19 | $0.00 | |
| 89051 | 33 | 27 | $0.00 | |
| 83540 | 44 | 37 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 41 | 38 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 27 | 25 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 21 | 19 | $0.00 |
| 84295 | 18 | 13 | $0.00 | |
| 36600 | 27 | 26 | $0.00 | |
| 82570 | 43 | 39 | $0.00 | |
| 87400 | 210 | 141 | $0.00 | |
| 76125 | 24 | 24 | $0.00 | |
| 84460 | 14 | 12 | $0.00 | |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 14 | 13 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 12 | 12 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 28 | 25 | $0.00 |
| 74300 | 12 | 12 | $0.00 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 15 | 12 | $0.00 |
| 64447 | 14 | 12 | $0.00 |